E-ISSN 2146-9369 | ISSN 2146-3158
 

Case Report 


Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report

Uğur Önal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Hüsnü Pullukçu, Sercan Ulusoy, Oğuz Reşat Sipahi.


Abstract
In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery. There was no relapse on 6 month post-treatment follow-up. We conclude that combination of antifungal antibiotics with deferasirox may be successful in the salvage therapy of mucormycosis especially in diabetic patients. J Microbiol Infect Dis 2016;6(1): 32-35
Onal U, Tasbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report, J Microbiol Infect Dis 2016;6(1):32-35 doi: 10.5799/ahinjs.02.2016.01.0211


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Uğur Önal
Articles by Meltem Taşbakan
Articles by Tansu Yamazhan
Articles by Bilgin Arda
Articles by Hüsnü Pullukçu
Articles by Sercan Ulusoy
Articles by Oğuz Reşat Sipahi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Onal U, Taşbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. J Microbiol Infect Dis. 2016; 6(1): 32-35 . doi:10.5799/jmid2016.01.0211


Web Style

Onal U, Taşbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. https://www.jmidonline.org/?mno=302657365 [Access: January 09, 2025]. doi:10.5799/jmid2016.01.0211


AMA (American Medical Association) Style

Onal U, Taşbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. J Microbiol Infect Dis. 2016; 6(1): 32-35 . doi:10.5799/jmid2016.01.0211



Vancouver/ICMJE Style

Onal U, Taşbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. J Microbiol Infect Dis. (2016), [cited January 09, 2025]; 6(1): 32-35 . doi:10.5799/jmid2016.01.0211



Harvard Style

Onal, U., Taşbakan, . M., Yamazhan, . T., Arda, . B., Pullukcu, . H., Ulusoy, . S. & Sipahi, . O. R. (2016) Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. J Microbiol Infect Dis, 6 (1), 32-35 . doi:10.5799/jmid2016.01.0211



Turabian Style

Onal, Uğur, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, and Oğuz Reşat Sipahi. 2016. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. Journal of Microbiology and Infectious Diseases, 6 (1), 32-35 . doi:10.5799/jmid2016.01.0211



Chicago Style

Onal, Uğur, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, and Oğuz Reşat Sipahi. "Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report." Journal of Microbiology and Infectious Diseases 6 (2016), 32-35 . doi:10.5799/jmid2016.01.0211



MLA (The Modern Language Association) Style

Onal, Uğur, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, and Oğuz Reşat Sipahi. "Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report." Journal of Microbiology and Infectious Diseases 6.1 (2016), 32-35 . Print. doi:10.5799/jmid2016.01.0211



APA (American Psychological Association) Style

Onal, U., Taşbakan, . M., Yamazhan, . T., Arda, . B., Pullukcu, . H., Ulusoy, . S. & Sipahi, . O. R. (2016) Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report. Journal of Microbiology and Infectious Diseases, 6 (1), 32-35 . doi:10.5799/jmid2016.01.0211